Citation Impact
Citing Papers
CRISPR–Cas9 Structures and Mechanisms
2017 StandoutNobel
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis
2013 Standout
Induction of human neuronal cells by defined transcription factors
2011 StandoutNatureNobel
dCas9 fusion to computer-designed PRC2 inhibitor reveals functional TATA box in distal promoter region
2022 StandoutNobel
Precise Correction of the Dystrophin Gene in Duchenne Muscular Dystrophy Patient Induced Pluripotent Stem Cells by TALEN and CRISPR-Cas9
2014 Nobel
Improved bi-allelic modification of a transcriptionally silent locus in patient-derived iPSC by Cas9 nickase
2016 StandoutNobel
Controlling CRISPR-Cas9 with ligand-activated and ligand-deactivated sgRNAs
2019 StandoutNobel
Germline development from human pluripotent stem cells toward disease modeling of infertility
2012 StandoutNobel
Stage-Specific Optimization of Activin/Nodal and BMP Signaling Promotes Cardiac Differentiation of Mouse and Human Pluripotent Stem Cell Lines
2011
A Mechanical Checkpoint Controls Multicellular Growth through YAP/TAZ Regulation by Actin-Processing Factors
2013 Standout
Induced pluripotent stem cells (iPSCs) and neurological disease modeling: progress and promises
2011
A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells
2010
Induced pluripotent stem cells — opportunities for disease modelling and drug discovery
2011
Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA
2014 Standout
Constitutive heterochromatin reorganization during somatic cell reprogramming
2011
Modeling familial Alzheimer's disease with induced pluripotent stem cells
2011 StandoutNobel
Reprogramming of Somatic Cells to Pluripotency
2010 StandoutNobel
Constructing and Deconstructing Stem Cell Models of Neurological Disease
2011
The Use of Induced Pluripotent Stem Cells in Drug Development
2011 StandoutNobel
ALS mutations in TLS/FUS disrupt target gene expression
2015
CRISPR-Cas9 Circular Permutants as Programmable Scaffolds for Genome Modification
2019 StandoutNobel
Erosion of Dosage Compensation Impacts Human iPSC Disease Modeling
2012
Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers
2015
Technical Challenges in Using Human Induced Pluripotent Stem Cells to Model Disease
2009
X chromosome inactivation in human and mouse pluripotent stem cells
2011
Induced pluripotency: history, mechanisms, and applications
2010
Mechanisms of nuclear reprogramming by eggs and oocytes: a deterministic process?
2011 StandoutNobel
Epigenetic control of Hox genes during neurogenesis, development, and disease
2010
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
2015 Standout
Applications of CRISPR–Cas systems in neuroscience
2015
Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
2017 StandoutNobel
Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR protein
2012
Rapid Single-Step Induction of Functional Neurons from Human Pluripotent Stem Cells
2013 StandoutNobel
The hypoxic tumor microenvironment: A driving force for breast cancer progression
2015 StandoutNobel
Long non-coding RNAs: new players in cell differentiation and development
2013 Standout
Epigenetics of induced pluripotency, the seven-headed dragon
2010
Widespread Translational Remodeling during Human Neuronal Differentiation
2017 StandoutNobel
Intercalation and delamination of layered carbides and carbonitrides
2013 Standout
Induced pluripotent stem cells and reprogramming: seeing the science through the hype
2009 StandoutNobel
Genome engineering using the CRISPR-Cas9 system
2013 Standout
Cystic fibrosis genetics: from molecular understanding to clinical application
2014 Standout
Genetic and Epigenetic Variations in iPSCs: Potential Causes and Implications for Application
2013
Adeno-associated virus vector as a platform for gene therapy delivery
2019 Standout
Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids
2018 StandoutNobel
Systemic Delivery of MeCP2 Rescues Behavioral and Cellular Deficits in Female Mouse Models of Rett Syndrome
2013
Applications of CRISPR technologies in research and beyond
2016 StandoutNobel
The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
2011
Transcriptional regulation and nuclear reprogramming: roles of nuclear actin and actin-binding proteins
2012 StandoutNobel
Modeling psychiatric disorders at the cellular and network levels
2012
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
2016 Standout
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
CNVs: Harbingers of a Rare Variant Revolution in Psychiatric Genetics
2012
Induced pluripotent stem cells: a new revolution for clinical neurology?
2011
Pluripotent stem cells in neurodegenerative and neurodevelopmental diseases
2010
The Human Brain in a Dish: The Promise of iPSC-Derived Neurons
2011
Unexpected X Chromosome Skewing during Culture and Reprogramming of Human Somatic Cells Can Be Alleviated by Exogenous Telomerase
2011
MECP2 Is Post-transcriptionally Regulated during Human Neurodevelopment by Combinatorial Action of RNA-Binding Proteins and miRNAs
2016
Induced Neuronal Cells: How to Make and Define a Neuron
2011 StandoutNobel
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
Organoid single-cell genomic atlas uncovers human-specific features of brain development
2019 StandoutNatureNobel
Modeling Development and Disease with Organoids
2016 Standout
Quantitative assessment on the cloning efficiencies of lentiviral transfer vectors with a unique clone site
2012
Efficient and Scalable Purification of Cardiomyocytes from Human Embryonic and Induced Pluripotent Stem Cells by VCAM1 Surface Expression
2011 StandoutNobel
Comprehensive qPCR profiling of gene expression in single neuronal cells
2011 StandoutNobel
Optimizing Promoters for Recombinant Adeno-Associated Virus-Mediated Gene Expression in the Peripheral and Central Nervous System Using Self-Complementary Vectors
2011
Derivation Conditions Impact X-Inactivation Status in Female Human Induced Pluripotent Stem Cells
2012 StandoutNobel
Hypoxia-inducible factor 1 mediates TAZ expression and nuclear localization to induce the breast cancer stem cell phenotype
2014 StandoutNobel
An Efficient Nonviral Method to Generate Integration-Free Human-Induced Pluripotent Stem Cells from Cord Blood and Peripheral Blood Cells
2012 StandoutNobel
Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome
2011
From Genomics to Gene Therapy: Induced Pluripotent Stem Cells Meet Genome Editing
2015 Nobel
Rapid and Deep Profiling of Human Induced Pluripotent Stem Cell Proteome by One-shot NanoLC–MS/MS Analysis with Meter-scale Monolithic Silica Columns
2012 StandoutNobel
Genomes in Focus: Development and Applications of CRISPR‐Cas9 Imaging Technologies
2017 StandoutNobel
Modeling hepatitis C virus infection using human induced pluripotent stem cells
2012 StandoutNobel
CRISPR-Cas: biology, mechanisms and relevance
2016 StandoutNobel
Epigenetic regulation in pluripotent stem cells: a key to breaking the epigenetic barrier
2012 StandoutNobel
Complementary roles of gasotransmitters CO and H2S in sleep apnea
2017 StandoutNobel
HIF-1α and TAZ serve as reciprocal co-activators in human breast cancer cells
2015 StandoutNobel
Azimuthal Polarization Filtering for Accurate, Precise, and Robust Single-Molecule Localization Microscopy
2014 StandoutNobel
Neurons generated by direct conversion of fibroblasts reproduce synaptic phenotype caused by autism-associated neuroligin-3 mutation
2013 StandoutNobel
Differences and similarities between human and chimpanzee neural progenitors during cerebral cortex development
2016 StandoutNobel
Works of Aaron Cheung being referenced
EOS lentiviral vector selection system for human induced pluripotent stem cells
2009
Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency
2009
Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation
2011
Over-Expression of Either MECP2_e1 or MECP2_e2 in Neuronally Differentiated Cells Results in Different Patterns of Gene Expression
2014
MECP2 Isoform-Specific Vectors with Regulated Expression for Rett Syndrome Gene Therapy
2009